Vardenafil Hydrochloride Tablet
Product Images NDC 62135-864

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Vardenafil Hydrochloride (NDC 62135-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Vardenafil HCl 2pt5mg Bottle Label)

Vardenafil Hydrochloride oral tablets, 2.5 mg strength, packaged by Chartwell RX, LLC. The label indicates prescription-only use, a package count of 30 tablets, and includes a barcode and handling instructions. It also references patient information available online and notes that no varnish is applied to the packaging.*

FDA Label Image

Image Description (Vardenafil HCl Graph 1)

A three-panel line graph depicting mean maximal changes in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) over time points 24h, 8h, 4h, and 1h related to timing of Vardenafil treatment pre-NTG. Each panel shows trend lines with error bars indicating variability at each time point.*

FDA Label Image

Image Description (Vardenafil HCl Graph 2)

A line graph showing the mean change in mmHg over time (hours) comparing placebo and vardenafil 5 mg under simultaneous and 6-hour separation dosing conditions. The graph includes four lines representing placebo simultaneous, placebo 6-hour separation, vardenafil 5 mg simultaneous, and vardenafil 5 mg 6-hour separation, with mean change values plotted from 0 to 6 hours.*

FDA Label Image

Image Description (Vardenafil HCl Graph 3)

A line graph showing mean change in mmHg over time (hours) comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. The x-axis represents time in hours from 0 to 6, and the y-axis shows mean change in mmHg, ranging from -15 to 15. Four data series are plotted with different markers and line styles to distinguish placebo and Vardenafil effects under both conditions.*

FDA Label Image

Image Description (Vardenafil HCl Graph 4)

A line graph illustrating the mean change in mmHg over time (0 to 6 hours) comparing placebo and Vardenafil at 10 mg and 20 mg doses in two stages. The y-axis represents mean change in mmHg, and the x-axis shows time in hours. Data points show trends of decreasing mean change for Vardenafil compared to placebo.*

FDA Label Image

Image Description (Vardenafil HCl Graph 5)

A line graph showing mean change in blood pressure (mmHg) over time (hours) for placebo and vardenafil at 5 mg and 10 mg doses. The graph compares two stages of placebo and two vardenafil dose groups, with time on the x-axis (0 to 6 hours) and mean change on the y-axis (-10 to 10 mmHg).*

FDA Label Image

Image Description (Vardenafil HCl Graph 6)

A line graph titled 'TERAZOSIN' showing mean change in mmHg over time in hours. It compares the effects of placebo, 10 mg Vardenafil, and 20 mg Vardenafil under 6-hour separation and simultaneous conditions, with multiple lines and markers representing each treatment group.*

FDA Label Image

Image Description (Vardenafil HCl Graph 7)

A line graph illustrating the mean change in mmHg over 6 hours in response to Tamsulosin combined with different doses of Vardenafil (10 mg and 20 mg) compared to placebo. The graph shows data for two conditions: 6-hour separation and simultaneous administration, with mean pressure changes plotted against time in hours from 0 to 6.*

FDA Label Image

Image Description (Vardenafil HCl Graph 8)

A line graph showing plasma concentration (µg/L) of Vardenafil Hydrochloride over time (hours). The graph illustrates the absorption and elimination profile of the drug with concentration peaking early and gradually declining to near zero by 24 hours post-dose.*

FDA Label Image

Image Description (Vardenafil HCl Structure)

Chemical structure of Vardenafil Hydrochloride showing the molecular framework with the hydrochloride and trihydrate components indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.